Identifying DNA variants associated with bronchodilator responsiveness may reveal genetic pathways associated with the pathogenesis of chronic obstructive pulmonary disease and may identify novel treatment methods, researchers have said.
Identifying DNA variants associated with bronchodilator responsiveness may reveal genetic pathways associated with the pathogenesis of chronic obstructive pulmonary disease and may identify novel treatment methods, researchers have said.